Key facts
- MediTuner’s last known valuation is $13.1M (Dec 2024).
- It has raised $8.5M; the latest was Later Stage VC ($2.1M) in Dec 2024.
- Notable investors include Almi Invest, Nordic Mentor Network For Entrepreneurship, Butterfly Ventures, California Life Sciences, DRIVE ( KI Innovations Business Incubator) — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for MediTuner
- ·The full record, as it builds
Funding rounds
No funding rounds for MediTuner are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MediTuner
Developer of digital respiratory care tools designed to facilitate automated self-management and clinical monitoring for chronic lung conditions. The company offers a mobile application that tracks inhalation technique and lung function via an electronic spirometer while providing automated medication adjustments and real-time data sharing with healthcare professionals through a web portal, enabling asthma patients to receive precise clinical guidance and improved control over their respiratory health.
- Sector
- Healthcare
- HQ
- Ramsey, MN, United States
- Founded
- 2014
- Employees
- 24
- Website
- medituner.com/
- Ownership
- Privately Held (backing)
MediTuner doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MediTuner shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MediTuner in its N-PORT filings yet. We sweep new filings monthly.